Meier-Gorlin syndrome and Wolf-Hirschhorn syndrome: Two developmental disorders highlighting the importance of efficient DNA replication for normal development and neurogenesis

DNA Repair

Volumn 12, Issue 8, 2013, Pages 637-644

  Kerzendorfer, Claudia ^a   Colnaghi, Rita ^a   Abramowicz, Iga ^a   Carpenter, Gillian ^a   O'Driscoll, Mark ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

DNA replication; Dormant origins; Microcephaly; Nucleosome assembly; Origin licensing

Indexed keywords

ARTICLE; CELL CYCLE S PHASE; DEVELOPMENTAL DISORDER; DNA DAMAGE; DNA REPLICATION; GENE; GENE MUTATION; HUMAN; MEIER GORLIN SYNDROME; NERVOUS SYSTEM DEVELOPMENT; ORIGIN RECOGNITION COMPLEX 1 GENE; PRIORITY JOURNAL; WOLF HIRSCHHORN SYNDROME;

DNA REPLICATION; DORMANT ORIGINS; MICROCEPHALY; NUCLEOSOME ASSEMBLY; ORIGIN LICENSING;

ANIMALS; CELL DIVISION; CENTRIOLES; CENTROSOME; DEVELOPMENTAL DISABILITIES; DISEASE MODELS, ANIMAL; DNA REPLICATION; EAR; GROWTH DISORDERS; HUMANS; MICROCEPHALY; MICROGNATHISM; NEUROGENESIS; PATELLA; WOLF-HIRSCHHORN SYNDROME;

EID: 84880584798     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2013.04.016     Document Type: Article

References (105)

1. Rakic P. A small step for the cell, a giant leap for mankind: a hypothesis of neocortical expansion during evolution. Trends Neurosci. 1995, 18:383-388.
2. Fish J.L., Kosodo Y., Enard W., Pääbo S., Huttner W.B. Aspm specifically maintains symmetric proliferative divisions of neuroepithelial cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10438-10443.
3. Thornton G.K., Woods C.G. Primary microcephaly: do all roads lead to Rome?. Trends Genet. 2009, 25:501-510.
4. Griffith E., Walker S., Martin C.-A., Vagnarelli P., Stiff T., Vernay B., Sanna N.A., Saggar A., Hamel B., Earnshaw W.C., Jeggo P.A., Jackson A.P., O'Driscoll M. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat. Genet. 2008, 40:232-236.
5. Rauch A., Thiel C.T., Schindler D., Wick U., Crow Y.J., Ekici A.B., van Essen A.J., Goecke T.O., Al-Gazali L., Chrzanowska K.H., Zweier C., Brunner H.G., Becker K., Curry C.J., Dallapiccola B., Devriendt K., Dorfler A., Kinning E., Megarbane A., Meinecke P., Semple R.K., Spranger S., Toutain A., Trembath R.C., Voss E., Wilson L., Hennekam R., de Zegher F., Dorr H.-G., Reis A. Mutations in the pericentrin (PCNT) gene cause Primordial Dwarfism. Science 2008, 319:816-819.
6. O'Driscoll M., Ruiz-Perez V.L., Woods C.G., Jeggo P.A., Goodship J.A. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 2003, 33:497-501.
7. Ogi T., Walker S., Stiff T., Hobson E., Limsirichaikul S., Prescott K., Suri M., Byrd P.J., Matsuse M., Mitsutake N., Nakazawa Y., Vasudevan P., Barrow M., Stewart G.S., Taylor A.M.R., O'Driscoll M., Jeggo P.A. Identification of the first ATRIP-deficient patient and novel mutations in ATR define a clinical spectrum for ATR-ATRIP Seckel syndrome. PLoS Genet. 2012, 8:e1002945.
8. Mokrani-Benhelli H., Gaillard L., Biasutto P., Le Guen T., Touzot F., Vasquez N., Komatsu J., Conseiller E., Pïcard C., Gluckman E., Francannet C., Fischer A., Durandy A., Soulier J., de Villartay J.-P., Cavazzana-Calvo M., Revy P. Primary Microcephaly, impaired DNA replication, and genomic instability caused by compound heterozygous ATR mutations. Hum. Mutat. 2012, 34:374-384.
9. Alderton G.K., Joenje H., Varon R., Borglum A.D., Jeggo P.A., O'Driscoll M. Seckel syndrome exhibits cellular features demonstrating defects in the ATR signalling pathway. Hum. Mol. Genet. 2004, 13:3127-3138.
10. Alderton G.K., Galbiati L., Griffith E., Surinya K.H., Neitzel H., Jackson A.P., Jeggo P.A., O'Driscoll M. Regulation of mitotic entry by microcephalin and its overlap with ATR signalling. Nat. Cell Biol. 2006, 8:725-733.
11. Brown E.J., Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 2000, 14:397-402.
12. Cortez D., Guntuku S., Qin J., Elledge S.J. ATR and ATRIP: partners in checkpoint signaling. Science 2001, 294:1713-1716.
13. de Klein A., Muijtjens M., van Os R., Verhoeven Y., Smit B., Carr A.M., Lehmann A.R., Hoeijmakers J.H.J. Targeted disruption of the cell cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol. 2000, 10:479-482.
14. Murga M., Bunting S., Montana M.F., Soria R., Mulero F., Canamero M., Lee Y., McKinnon P.J., Nussenzweig A., Fernandez-Capetillo O. A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging. Nat. Genet. 2009, 41:891-898.
15. Ruzankina Y., Pinzon-Guzman C., Asare A., Ong T., Pontano L., Cotsarelis G., Zediak V.P., Velez M., Bhandoola A., Brown E.J. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 2007, 1:113-126.
16. O'Driscoll M. Mouse models for ATR deficiency. DNA Repair 2009, 8:1333-1337.
17. Toledo L.I., Murga M., Fernandez-Capetillo O., Targeting A.T.R Chk1 kinases for cancer treatment: a new model for new (and old) drugs. Mol. Oncol. 2011, 5:368-373.
18. Gorlin R., Cervenka J., Moller K., Horrobin M., Witkop C.J. Malformation syndromes. A selected miscellany. Birth Defects Orig. Artic. Ser. 1975, 11:39-50.
19. Bongers E., Van Kampen A., Van Bokhoven H., Knoers N. Human syndromes with congenital patellar anomalies and the underlying gene defects. Clin. Genet. 2005, 68:302-319.
20. Bongers E.M.H.F., Opitz J.M., Fryer A., Sarda P., Hennekam R.C.M., Hall B.D., Superneau D.W., Harbison M., Poss A., Bokhoven H.v., Hamel B.C.J., Knoers N.V.A.M. Meier-Gorlin syndrome: report of eight additional cases and review. Am. J. Med. Genet. 2001, 102:115-124.
21. Bongers E.M.H.F., Van Bokhovan H., Van Thienen M.-N., Kooyman M.A.P., Van Beersum S.E.C., Boetes C., Knoers N.V.A.M., Hamel B.C.J. The small patella syndrome: description of five cases from three families and examination of possible allelism with familial patella aplasia-hypoplasia and nail-patella syndrome. J. Med. Genet. 2001, 38:209-214.
22. Bicknell L.S., Bongers E.M.H.F., Leitch A., Brown S., Schoots J., Harley M.E., Aftimos S., Al-Aama J.Y., Bober M., Brown P.A.J., van Bokhoven H., Dean J., Edrees A.Y., Feingold M., Fryer A., Hoefsloot L.H., Kau N., Knoers N.V.A.M., MacKenzie J., Opitz J.M., Sarda P., Ross A., Temple I.K., Toutain A., Wise C.A., Wright M., Jackson A.P. Mutations in the pre-replication complex cause Meier-Gorlin syndrome. Nat. Genet. 2011, 43:356-359.
23. Bicknell L.S., Walker S., Klingseisen A., Stiff T., Leitch A., Kerzendorfer C., Martin C.-A., Yeyati P., Al Sanna N., Bober M., Johnson D., Wise C., Jackson A.P., O'Driscoll M., Jeggo P.A. Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause Microcephalic Primordial Dwarfism resembling Meier-Gorlin syndrome. Nat. Genet. 2011, 43:350-355.
24. Guernsey D.L., Matsuoka M., Jiang H., Evans S., Macgillivray C., Nightingale M., Perry S., Ferguson M., LeBlanc M., Paquette J., Patry L., Rideout A.L., Thomas A., Orr A., McMaster C.R., Michaud J.L., Deal C., Langlois S., Superneau D.W., Parkash S., Ludman M., Skidmore D.L., Samuels M.E. Mutations in origin recognition complex gene ORC4 cause Meier-Gorlin syndrome. Nat. Genet. 2011, 43:360-364.
25. Blow J.J., Ge X.Q., Jackson D.A. How dormant origins promote complete genome replication. Trends Biochem. Sci. 2011, 36:405-414.
26. Woodward A.M., Gohler T., Luciani M.G., Oehlmann M., Ge X., Gartner A., Jackson D.A., Blow J.J. Excess Mcm2-7 license dormant origins of replication that can be used under conditions of replicative stress. J. Cell Biol. 2006, 173:673-683.
27. Kawabata T., Luebben S.W., Yamaguchi S., Ilves I., Matise I., Buske T., Botchan M.R., Shima N. Stalled fork rescue via dormant replication origins in unchallenged S phase promotes proper chromosome segregation and tumor suppression. Mol. Cell 2011, 41:543-553.
28. Blow J.J., Ge X.Q. A model for DNA replication showing how dormant origins safeguard against replication fork failure. EMBO Rep. 2009, 10:406-412.
29. Ibarra A., Schwob E., Méndez J. Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8956-8961.
30. Ge X.Q., Jackson D.A., Blow J.J. Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress. Genes Dev. 2007, 21:3331-3341.
31. Goodship J., Gill H., Carter J., Jackson A., Splitt M., Wright M. Autozygosity mapping of a seckel syndrome locus to chromosome 3q22. 1-q24. Am. J. Hum. Genet. 2000, 67:498-503.
32. de Munnik S.A., Otten B.J., Schoots J., Bicknell L.S., Aftimos S., Al-Aama J.Y., van Bever Y., Bober M.B., Borm G.F., Clayton-Smith J., Deal C.L., Edrees A.Y., Feingold M., Fryer A., van Hagen J.M., Hennekam R.C., Jansweijer M.C.E., Johnson D., Kant S.G., Opitz J.M., Ramadevi A.R., Reardon W., Ross A., Sarda P., Schrander-Stumpel C.T.R.M., Sluiter A.E., Temple I.K., Terhal P.A., Toutain A., Wise C.A., Wright M., Skidmore D.L., Samuels M.E., Hoefsloot L.H., Knoers N.V.A.M., Brunner H.G., Jackson A.P., Bongers E.M.H.F. Meier-Gorlin syndrome: growth and secondary sexual development of a Microcephalic Primordial Dwarfism disorder. Am. J. Med. Genet. A 2012, 158A:2733-2742.
33. Kuo A.J., Song J., Cheung P., Ishibe-Murakami S., Yamazoe S., Chen J.K., Patel D.J., Gozani O. The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier-Gorlin syndrome. Nature 2012, 484:115-119.
34. Noguchi K., Vassilev A., Ghosh S., Yates J.L., DePamphilis M.L. The BAH domain facilitates the ability of human Orc1 protein to activate replication origins in vivo. EMBO J. 2006, 25:5372-5382.
35. Kunnev D., Rusiniak M.E., Kudla A., Freeland A., Cady G.K., Pruitt S.C. DNA damage response and tumorigenesis in Mcm2-deficient mice. Oncogene 2010, 29:3630-3638.
36. Shima N., Alcaraz A., Liachko I., Buske T.R., Andrews C.A., Munroe R.J., Hartford S.A., Tye B.K., Schimenti J.C. A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat. Genet. 2007, 39:93-98.
37. de Munnik S.A., Bicknell L.S., Aftimos S., Al-Aama J.Y., van Bever Y., Bober M.B., Clayton-Smith J., Edrees A.Y., Feingold M., Fryer A., van Hagen J.M., Hennekam R.C., Jansweijer M.C.E., Johnson D., Kant S.G., Opitz J.M., Ramadevi A.R., Reardon W., Ross A., Sarda P., Schrander-Stumpel C.T.R.M., Schoots J., Temple I.K., Terhal P.A., Toutain A., Wise C.A., Wright M., Skidmore D.L., Samuels M.E., Hoefsloot L.H., Knoers N.V.A.M., Brunner H.G., Jackson A.P., Bongers E.M.H.F. Meier-Gorlin syndrome genotype-phenotype studies: 35 individuals with pre-replication complex gene mutations and 10 without molecular diagnosis. Eur. J. Hum. Genet. 2012, 20:598-606.
38. Casey J.P., Nobbs M., McGettigan P., Lynch S., Ennis S. Recessive mutations in MCM4/PRKDC cause a novel syndrome involving a primary immunodeficiency and a disorder of DNA repair. J. Med. Genet. 2012, 49:242-245.
39. Hughes C.R., Guasti L., Meimaridou E., Chuang C.-H., Schimenti J.C., King P.J., Costigan C., Clark A.J.L., Metherell L.A. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J. Clin. Invest. 2012, 122:814-820.
40. Gineau L., Cognet C., Kara N., Lach F.P., Dunne J., Veturi U., Picard C., Trouillet C., Eidenschenk C., Aoufouchi S., Alcaïs A., Smith O., Geissmann F., Feighery C., Abel L., Smogorzewska A., Stillman B., Vivier E., Casanova J.-L., Jouanguy E. Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J. Clin. Invest. 2012, 122:821-832.
41. Pruitt S.C., Bailey K.J., Freeland A. Reduced Mcm2 expression results in severe stem/progenitor cell deficiency and cancer. Stem Cells 2007, 25:3121-3132.
42. Hemerly A.S., Prasanth S.G., Siddiqui K., Stillman B. Orc1 controls centriole and centrosome copy number in human cells. Science 2009, 323:789-793.
43. Prasanth S.G., Shen Z., Prasanth K.V., Stillman B. Human origin recognition complex is essential for HP1 binding to chromatin and heterochromatin organization. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15093-15098.
44. Prasanth S.G., Prasanth K.V., Siddiqui K., Spector D.L., Stillman B. Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance. EMBO J. 2004, 23:2651-2663.
45. Huang Z., Zang K., Reichardt L.F. The origin recognition core complex regulates dendrite and spine development in postmitotic neurons. J. Cell Biol. 2005, 170:527-535.
46. Rohrbough J., Pinto S., Mihalek R.M., Tully T., Broadie K. latheo, a Drosophila gene involved in learning, regulates functional synaptic plasticity. Neuron 1999, 23:55-70.
47. Pinto S., Quintana D.G., Smith P., Mihalek R.M., Hou Z.-H., Boynton S., Jones C.J., Hendricks M., Velinzon K., Wohlschlegel J.A., Austin R.J., Lane W.S., Tully T., Dutta A. latheo encodes a subunit of the origin recognition complex and disrupts neuronal proliferation and adult olfactory memory when mutant. Neuron 1999, 23:45-54.
48. Hirschhorn K., Cooper H.L. Apparent deletion of short arms of one chromosome (4 or 5) in a child with defects of midline fusion. Hum. Chromosome Newslett. IV 1961, 14.
49. Hirschhorn K., Cooper H.L., Firschein I.L. Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion. Humangenetik 1965, 1:479-482.
50. Wolf U., Reinwein H., Porsch R., Schröter R., Baitsch H. Defizienz an den kurzen Armen eines Chromosoms Nr. 4. Humangenetik 1965, 1:397.
51. Maas N.M.C., Van Buggenhout G., Hannes F., Thienpont B., Sanlaville D., Kok K., Midro A., Andrieux J., Anderlid B.-M., Schoumans J., Hordijk R., Devriendt K., Fryns J.-P., Vermeesch J.R. Genotype-phenotype correlation in 21 patients with Wolf-Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH). J. Med. Genet. 2008, 45:71-80.
52. Antonius T., Draaisma J., Levtchenko E., Knoers N., Renier W., Ravenswaaij C. Growth charts for Wolf-Hirschhorn syndrome (0-4 years of age). Eur. J. Pediatr. 2008, 167:807-810.
53. 2+-binding protein, flanks the Wolf-Hirschhorn Syndrome (WHS) critical region and is deleted in most WHS patients. Genomics 1999, 60:218-225.
54. Battaglia A., Filippi T., South S.T., Carey J.C. Spectrum of epilepsy and electroencephalogram patterns in Wolf-Hirschhorn syndrome: experience with 87 patients. Dev. Med. Child Neurol. 2009, 51:373-380.
55. + antiporter. Science 2009, 326:144-147.
56. White D.M., Pillers D.A., Reiss J.A., Brown M.G., Magenis R.E. Interstitial deletions of the short arm of chromosome 4 in patients with a similar combination of multiple minor anomalies and mental retardation. Am. J. Med. Genet. 1995, 57:588-597.
57. Wright T.J., Ricke D.O., Denison K., Abmayr S., Cotter P.D., Hirschhorn K., Keinänen M., McDonald-McGinn D., Somer M., Spinner N., Yang-Feng T., Zackai E., Altherr M.R. A transcript map of the newly defined 165kb Wolf-Hirschhorn syndrome critical region. Hum. Mol. Genet. 1997, 6:317-324.
58. Narita T., Yung T.M.C., Yamamoto J., Tsuboi Y., Tanabe H., Tanaka K., Yamaguchi Y., Handa H. NELF interacts with CBC and participates in 3' end processing of replication-dependent histone mRNAs. Mol. Cell 2007, 26:349-365.
59. Gilchrist D.A., Nechaev S., Lee C., Ghosh S.K.B., Collins J.B., Li L., Gilmour D.S., Adelman K. NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly. Genes Dev. 2008, 22:1921-1933.
60. Yung T.M.C., Narita T., Komori T., Yamaguchi Y., Handa H. Cellular dynamics of the negative transcription elongation factor NELF. Exp. Cell Res. 2009, 315:1693-1705.
61. Zhao X., McKillop-Smith S., Muller B. The human histone gene expression regulator HBP/SLBP is required for histone and DNA synthesis, cell cycle progression and cell proliferation in mitotic cells. J. Cell Sci. 2004, 117:6043-6051.
62. Bonner W.M., Wu R.S., Panusz H.T., Muneses C. Kinetics of accumulation and depletion of soluble newly synthesized histone in the reciprocal regulation of histone and DNA synthesis. Biochemistry 1998, 23:6542-6550.
63. Marzluff W.F., Wagner E.J., Duronio R.J. Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. Genet. 2008, 9:843-854.
64. Jaeger S., Barends S., Giegé R., Eriani G., Martin F. Expression of metazoan replication-dependent histone genes. Biochimie 2005, 87:827-834.
65. Allard P., Yang Q., Marzluff W.F., Clarke H.J. The stem-loop binding protein regulates translation of histone mRNA during mammalian oogenesis. Dev. Biol. 2005, 286:195-206.
66. Zheng L., Dominski Z., Yang X.-C., Elms P., Raska C.S., Borchers C.H., Marzluff W.F. Phosphorylation of Stem-Loop Binding Protein (SLBP) on two threonines triggers degradation of slbp the sole cell cycle-regulated factor required for regulation of histone mRNA processing, at the end of S phase. Mol. Cell. Biol. 2003, 23:1590-1601.
67. Margueron R., Reinberg D. Chromatin structure and the inheritance of epigenetic information. Nat. Rev. Genet. 2010, 11:285-296.
68. Sullivan K.D., Mullen T.E., Marzluff W.F., Wagner E.J. Knockdown of SLBP results in nuclear retention of histone mRNA. RNA 2009, 15:459-472.
69. Wagner E.J., Berkow A., Marzluff W.F. Expression of an RNAi-resistant SLBP restores proper S-phase progression. Biochem. Soc. Trans. 2005, 33:471-473.
70. Kerzendorfer C., Hannes F., Colnaghi R., Abramowicz I., Carpenter G., Vermeesch J.R., O'Driscoll M. Characterizing the functional consequences of haploinsufficiency of NELF-A (WHSC2) and SLBP identifies novel cellular phenotypes in Wolf-Hirschhorn syndrome. Hum. Mol. Genet. 2012, 21:2181-2193.
71. Jasencakova Z., Groth A. Replication stress, a source of epigenetic aberrations in cancer?. Bioessays 2010, 32:847-855.
72. Jasencakova Z., Groth A. Restoring chromatin after replication: how new and old histone marks come together. Sem. Cell Dev. Biol. 2010, 21:231-237.
73. Jasencakova Z., Scharf A.N.D., Ask K., Corpet A., Imhof A., Almouzni G., Groth A. Replication stress interferes with histone recycling and predeposition marking of new histones. Mol. Cell 2010, 37:736-743.
74. Megraw T.L., Sharkey J.T., Nowakowski R.S. Cdk5rap2 exposes the centrosomal root of microcephaly syndromes. Trends Cell Biol. 2011, 21:470-480.
75. Mahmood S., Ahmad W., Hassan M. Autosomal recessive primary microcephaly (MCPH): clinical manifestations, genetic heterogeneity and mutation continuum. Orphanet J. Rare Dis. 2011, 6:39.
76. Trimborn M., Schindler D., Neitzel H., Hirano T. Misregulated chromosome condensation in MCPH1 primary microcephaly is mediated by condensin II. Cell Cycle 2006, 5:322-326.
77. Trimborn M., Bell S.M., Felix C., Rashid Y., Jafri H., Griffiths P.D., Neumann L.M., Krebs A., Reis A., Sperling K., Neitzel H., Jackson A.P. Mutations in microcephalin cause aberrant regulation of chromosome condensation. Am. J. Hum. Genet. 2004, 75:261-266.
78. Yamashita D., Shintomi K., Ono T., Gavvovidis I., Schindler D., Neitzel H., Trimborn M., Hirano T. MCPH1 regulates chromosome condensation and shaping as a composite modulator of condensin II. J. Cell Biol. 2011, 194:841-854.
79. Trimborn M., Richter R., Sternberg N., Gavvovidis I., Schindler D., Jackson A.P., Prott E.-C., Sperling K., Gillessen-Kaesbach G., Neitzel H. The first missense alteration in the MCPH1 gene causes autosomal recessive microcephaly with an extremely mild cellular and clinical phenotype. Hum. Mutat. 2005, 26:496.
80. Bond R.E.J., Mochida G.H., Hampshire D.J., Scott S., Askham J.M., Springell K., Mahadevan M., Crow Y.J., Markham A.F., Walsh C.A., Woods C.G. ASPM is a major determinant of cerebral cortical size. Nat. Genet. 2002, 32:316-320.
81. Bond J., Roberts E., Springell K., Lizarraga S.B., Scott S., Higgins J., Hampshire D.J., Morrison E.E., Leal G.F., Silva E.O., Costa S.M., Baralle D., Raponi M., Karbani G., Rashid Y., Jafri H., Bennett C., Corry P., Walsh C.A., Woods C.G. A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size. Nat. Genet. 2005, 37:353-355.
82. Fong K.-W., Choi Y.-K., Rattner J.B., Qi R.Z. CDK5RAP2 is a pericentriolar protein that functions in centrosomal attachment of the γ-tubulin ring complex. Mol. Biol. Cell 2008, 19:115-125.
83. Graser S., Stierhof Y.-D., Nigg E.A. Cep68 and Cep215 (Cdk5rap2) are required for centrosome cohesion. J. Cell Sci. 2007, 120:4321-4331.
84. Barr A.R., Kilmartin J.V., Gergely F. CDK5RAP2 functions in centrosome to spindle pole attachment and DNA damage response. J. Cell Biol. 2010, 189:23-39.
85. Lizarraga S.B., Margossian S.P., Harris M.H., Campagna D.R., Han A.-P., Blevins S., Mudbhary R., Barker J.E., Walsh C.A., Fleming M.D. Cdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitors. Development 2010, 137:1907-1917.
86. Buchman J.J., Tseng H.-C., Zhou Y., Frank C.L., Xie Z., Tsai L.-H. Cdk5rap2 interacts with pericentrin to maintain the neural progenitor pool in the developing neocortex. Neuron 2010, 66:386-402.
87. Barrera J.A., Kao L.-R., Hammer R.E., Seemann J., Fuchs J.L., Megraw T.L. CDK5RAP2 regulates centriole engagement and cohesion in mice. Dev. Cell 2010, 18:913-926.
88. Choi Y.-K., Liu P., Sze S.K., Dai C., Qi R.Z. CDK5RAP2 stimulates microtubule nucleation by the γ-tubulin ring complex. J. Cell Biol. 2010, 191:1089-1095.
89. Al-Dosari M.S., Shaheen R., Colak D., Alkuraya F.S. Novel CENPJ mutation causes Seckel syndrome. J. Med. Genet. 2010, 47:411-414.
90. Vulprecht J., David A., Tibelius A., Castiel A., Konotop G., Liu F., Bestvater F., Raab M.S., Zentgraf H., Izraeli S., Krämer A. STIL is required for centriole duplication in human cells. J. Cell Sci. 2012, 125:1353-1362.
91. Kitagawa D., Kohlmaier G., Keller D., Strnad P., Balestra F.R., Flückiger I., Gönczy P. Spindle positioning in human cells relies on proper centriole formation and on the microcephaly proteins CPAP and STIL. J. Cell Sci. 2011, 124:3884-3893.
92. Tang C.-J.C., Lin S.-Y., Hsu W.-B., Lin Y.-N., Wu C.-T., Lin Y.-C., Chang C.-W., Wu K.-S., Tang T.K. The human microcephaly protein STIL interacts with CPAP and is required for procentriole formation. EMBO J. 2011, 30:4790-4804.
93. Bilguvar K., Ozturk A.K., Louvi A., Kwan K.Y., Choi M., Tatli B., Yalnizoglu D., Tuysuz B., Caglayan A.O., Gokben S., Kaymakcalan H., Barak T., Bakircioglu M., Yasuno K., Ho W., Sanders S., Zhu Y., Yilmaz S., Dincer A., Johnson M.H., Bronen R.A., Kocer N., Per H., Mane S., Pamir M.N., Yalcinkaya C., Kumandas S., Topcu M., Ozmen M., Sestan N., Lifton R.P., State M.W., Gunel M. Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations. Nature 2010, 467:207-210.
94. Yu T.W., Mochida G.H., Tischfield D.J., Sgaier S.K., Flores-Sarnat L., Sergi C.M., Topcu M., McDonald M.T., Barry B.J., Felie J.M., Sunu C., Dobyns W.B., Folkerth R.D., Barkovich A.J., Walsh C.A. Mutations in WDR62, encoding a centrosome-associated protein, cause microcephaly with simplified gyri and abnormal cortical architecture. Nat. Genet. 2010, 42:1015-1020.
95. Nicholas A.K., Khurshid M., Desir J., Carvalho O.P., Cox J.J., Thornton G., Kausar R., Ansar M., Ahmad W., Verloes A., Passemard S., Misson J.-P., Lindsay S., Gergely F., Dobyns W.B., Roberts E., Abramowicz M., Woods C.G. WDR62 is associated with the spindle pole and is mutated in human microcephaly. Nat. Genet. 2010, 42:1010-1014.
96. Guernsey D.L., Jiang H., Hussin J., Arnold M., Bouyakdan K., Perry S., Babineau-Sturk T., Beis J., Dumas N., Evans S.C., Ferguson M., Matsuoka M., Macgillivray C., Nightingale M., Patry L., Rideout A.L., Thomas A., Orr A., Hoffmann I., Michaud J.L., Awadalla P., Meek D.C., Ludman M., Samuels M.E. Mutations in centrosomal protein CEP152 in primary microcephaly families linked to MCPH4. Am. J. Hum. Genet. 2010, 87:40-51.
97. Cizmecioglu O., Arnold M., Bahtz R., Settele F., Ehret L., Haselmann-Weiß U., Antony C., Hoffmann I. Cep152 acts as a scaffold for recruitment of Plk4 and CPAP to the centrosome. J. Cell Biol. 2010, 191:731-739.
98. Hatch E.M., Kulukian A., Holland A.J., Cleveland D.W., Stearns T. Cep152 interacts with Plk4 and is required for centriole duplication. J. Cell Biol. 2010, 191:721-729.
99. Kalay E., Yigit G., Aslan Y., Brown K.E., Pohl E., Bicknell L.S., Kayserili H., Li Y., Tuysuz B., Nurnberg G., Kiess W., Koegl M., Baessmann I., Buruk K., Toraman B., Kayipmaz S., Kul S., Ikbal M., Turner D.J., Taylor M.S., Aerts J., Scott C., Milstein K., Dollfus H., Wieczorek D., Brunner H.G., Hurles M., Jackson A.P., Rauch A., Nurnberg P., Karaguzel A., Wollnik B. CEP152 is a genome maintenance protein disrupted in Seckel syndrome. Nat. Genet. 2011, 43:23-26.
100. Sir J.-H., Barr A.R., Nicholas A.K., Carvalho O.P., Khurshid M., Sossick A., Reichelt S., D'Santos C., Woods C.G., Gergely F. A primary microcephaly protein complex forms a ring around parental centrioles. Nat. Genet. 2011, 43:1147-1153.
101. Smith E., Dejsuphong D., Balestrini A., Hampel M., Lenz C., Takeda S., Vindigni A., Costanzo V. An A.T.M- and ATR-dependent checkpoint inactivates spindle assembly by targeting CEP63. Nat. Cell Biol. 2009, 11:278-285.
102. Ohta T., Essner R., Ryu J.-H., Palazzo R.E., Uetake Y., Kuriyama R. Characterization of Cep135, a novel coiled-coil centrosomal protein involved in microtubule organization in mammalian cells. J. Cell Biol. 2002, 156:87-100.
103. Hussain M.S., Baig S.M., Neumann S., Nürnberg G., Farooq M., Ahmad I., Alef T., Hennies H.C., Technau M., Altmüller J., Frommolt P., Thiele H., Noegel A.A., Nürnberg P. A truncating mutation of CEP135 causes primary microcephaly and disturbed centrosomal function. Am. J. Hum. Genet. 2012, 90:871-878.
104. Kim K., Lee S., Chang J., Rhee K. A novel function of CEP135 as a platform protein of C-NAP1 for its centriolar localization. Exp. Cell Res. 2008, 314:3692-3700.
105. Dauber A., LaFranchi S.H., Maliga Z., Lui J.C., Moon J.E., McDeed C., Henke K., Zonana J., Kingman G.A., Pers T.H., Baron J., Rosenfeld R.G., Hirschhorn J.N., Harris M.P., Hwa V. Novel Microcephalic Primordial Dwarfism disorder associated with variants in the centrosomal protein ninein. J. Clin. Endocrinol. Metab. 2012, 97:E2140-E2151.